|
1
|
Nguyen QT, Lee EJ, Huang MG, Park YI,
Khullar A and Plodkowski RA: Diagnosis and treatment of patients
with thyroid cancer. Am Health Drug Benefits. 8:30–40.
2015.PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM,
Schlumberger M, et al: 2015 American thyroid association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The american thyroid association
guidelines task force on thyroid nodules and differentiated thyroid
cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bisarro Dos, Reis M, Barros-Filho MC,
Marchi FA, Beltrami CM, Kuasne H, Pinto CAL, Ambatipudi S, Herceg
Z, Kowalski LP and Rogatto SR: Prognostic classifier based on
genome-wide DNA methylation profiling in well-differentiated
thyroid tumors. J Clin Endocrinol Metab. 102:4089–4099. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fontaine JF, Mirebeau-Prunier D, Franc B,
Triau S, Rodien P, Houlgatte R, Malthièry Y and Savagner F:
Microarray analysis refines classification of non-medullary thyroid
tumours of uncertain malignancy. Oncogene. 27:2228–2236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luzón-Toro B, Bleda M, Navarro E,
Garcia-Alonso L, Ruiz-Ferrer M, Medina I, Martín-Sánchez M,
Gonzalez CY, Fernández RM, Torroglosa A, et al: Identification of
epistatic interactions through genome-wide association studies in
sporadic medullary and juvenile papillary thyroid carcinomas. BMC
Med Genomics. 8:832015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Handkiewicz-Junak D, Swierniak M, Rusinek
D, Oczko-Wojciechowska M, Dom G, Maenhaut C, Unger K, Detours V,
Bogdanova T, Thomas G, et al: Gene signature of the post-Chernobyl
papillary thyroid cancer. Eur J Nucl Med Mol Imaging. 43:1267–1277.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tomás G, Tarabichi M, Gacquer D, Hébrant
A, Dom G, Dumont JE, Keutgen X, Fahey TJ III, Maenhaut C and
Detours V: A general method to derive robust organ-specific gene
expression-based differentiation indices: Application to thyroid
cancer diagnostic. Oncogene. 31:4490–4498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Espinal-Enríquez J, Muñoz-Montero S,
Imaz-Rosshandler I, Huerta-Verde A, Mejía C and Hernández-Lemus E:
Genome-wide expression analysis suggests a crucial role of
dysregulation of matrix metalloproteinases pathway in
undifferentiated thyroid carcinoma. BMC Genomics. 16:2072015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao M, Wang KJ, Tan Z, Zheng CM, Liang Z
and Zhao JQ: Identification of potential therapeutic targets for
papillary thyroid carcinoma by bioinformatics analysis. Oncol Lett.
11:51–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Y, Bao Y, Ma M and Yang W:
Identification of key candidate genes and pathways in colorectal
cancer by integrated bioinformatical analysis. Int J Mol Sci.
18:E7222017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Peng L, Zhang Y, Liu Z, Li W,
Chen S and Li G: The identification of key genes and pathways in
hepatocellular carcinoma by bioinformatics analysis of
high-throughput data. Med Oncol. 34:1012017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu WH, Chen GY, Cui L, Zhang TM, Wei F
and Yang Y: Identification of differential pathways in papillary
thyroid carcinoma utilizing pathway co-expression analysis. J BUON.
21:1501–1509. 2016.PubMed/NCBI
|
|
15
|
Qu T, Li YP, Li XH and Chen Y:
Identification of potential biomarkers and drugs for papillary
thyroid cancer based on gene expression profile analysis. Mol Med
Rep. 14:5041–5048. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang Y, Tao Y, Li X, Chang S, Jiang B, Li
F and Wang ZM: Bioinformatics analysis of key genes and latent
pathway interactions based on the anaplastic thyroid carcinoma gene
expression profile. Oncol Lett. 13:167–176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu J, Zhang W, Xia Q, Liu F, Li L, Zhao
S, Gao X, Zang C, Ge R and Sun Y: RNA sequencing identifies crucial
genes in papillary thyroid carcinoma (PTC) progression. Exp Mol
Pathol. 100:151–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Min XS, Huang P, Liu X, Dong C, Jiang XL,
Yuan ZT, Mao LF and Chang S: Bioinformatics analyses of significant
prognostic risk markers for thyroid papillary carcinoma. Tumour
Biol. 36:7457–7463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen W, Liu Q, Lv Y, Xu D, Chen W and Yu
J: Special role of JUN in papillary thyroid carcinoma based on
bioinformatics analysis. World J Surg Oncol. 15:1192017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cancer Genome Atlas Research Network, .
Integrated genomic characterization of papillary thyroid carcinoma.
Cell. 159:676–690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu J, Mai W, Cui Y and Kong L: Key genes
and pathways predicted in papillary thyroid carcinoma based on
bioinformatics analysis. J Endocrinol Invest. 39:1285–1293. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, et al: Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:pp. 2803–2808. 2007;
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hilmarsdóttir B, Briem E, Sigurdsson V,
Franzdóttir SR, Ringnér M, Arason AJ, Bergthorsson JT, Magnusson MK
and Gudjonsson T: MicroRNA-200c-141 and ΔNp63 are required for
breast epithelial differentiation and branching morphogenesis. Dev
Biol. 403:150–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mi H, Huang X, Muruganujan A, Tang H,
Mills C, Kang D and Thomas PD: PANTHER version 11: Expanded
annotation data from Gene Ontology and Reactome pathways, and data
analysis tool enhancements. Nucleic Acids Res. 45:D183–D189. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng Q, Li KY, Chen H, Dai JH, Zhai YY,
Wang Q, Li N, Wang YP and Han ZG: RNA interference against
cancer/testis genes identifies dual specificity phosphatase 21 as a
potential therapeutic target in human hepatocellular carcinoma.
Hepatology. 59:518–530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang K, Niu Y, Wang Q, Liu H, Jin Y and
Zhang S: Cloning and evaluation of reference genes for quantitative
real-time PCR analysis in amorphophallus. Peer J. 5:e32602017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lefever S, Hellemans J, Pattyn F,
Przybylski DR, Taylor C, Geurts R, Untergasser A and Vandesompele
J; RDML RDML consortium, : Structured language and reporting
guidelines for real-time quantitative PCR data. Nucleic Acids Res.
37:2065–2069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jolly LA, Novitskiy S, Owens P, Massoll N,
Cheng N, Fang W, Moses HL and Franco AT: Fibroblast-mediated
collagen remodeling within the tumor microenvironment facilitates
progression of thyroid cancers driven by brafv600e and pten loss.
Cancer Res. 76:1804–1813. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saka E, Harrison BJ, West K, Petruska JC
and Rouchka EC: Framework for reanalysis of publicly available
affymetrix(R) genechip(R) data sets based on functional regions of
interest. BMC Genomics. 18 Suppl 10:S8752017. View Article : Google Scholar
|
|
39
|
Miyake M, Hori S, Morizawa Y, Tatsumi Y,
Toritsuka M, Ohnishi S, Shimada K, Furuya H, Khadka VS, Deng Y, et
al: Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha
1 (COL13A1) produced in cancer cells promote tumor budding at the
invasion front in human urothelial carcinoma of the bladder.
Oncotarget. 8:36099–36114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sercu S, Zhang L and Merregaert J: The
extracellular matrix protein 1: Its molecular interaction and
implication in tumor progression. Cancer Invest. 26:375–384. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kebebew E, Peng M, Reiff E, Duh QY, Clark
OH and McMillan A: ECM1 and TMPRSS4 are diagnostic markers of
malignant thyroid neoplasms and improve the accuracy of fine needle
aspiration biopsy. Ann Surg. 242:353–361; discussion 361–353.
2005.PubMed/NCBI
|
|
42
|
Waalkes S, Atschekzei F, Kramer MW,
Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS,
Schrader AJ, Kuczyk MA and Serth J: Fibronectin 1 mRNA expression
correlates with advanced disease in renal cancer. BMC Cancer.
10:5032010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sponziello M, Rosignolo F, Celano M,
Maggisano V, Pecce V, De Rose RF, Lombardo GE, Durante C, Filetti
S, Damante G, et al: Fibronectin-1 expression is increased in
aggressive thyroid cancer and favors the migration and invasion of
cancer cells. Mol Cell Endocrinol. 431:123–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xia S, Wang C, Postma EL, Yang Y, Ni X and
Zhan W: Fibronectin 1 promotes migration and invasion of papillary
thyroid cancer and predicts papillary thyroid cancer lymph node
metastasis. OncoTargets Ther. 10:1743–1755. 2017. View Article : Google Scholar
|
|
45
|
Vierlinger K, Mansfeld MH, Koperek O,
Nohammer C, Kaserer K and Leisch F: Identification of SERPINA1 as
single marker for papillary thyroid carcinoma through microarray
meta analysis and quantification of its discriminatory power in
independent validation. BMC Med Genomics. 4:302011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Porter JF, Shen S and Denhardt DT: Tissue
inhibitor of metalloproteinase-1 stimulates proliferation of human
cancer cells by inhibiting a metalloproteinase. Br J Cancer.
90:463–470. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fagerberg L, Hallstrom BM, Oksvold P,
Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S,
Danielsson A, Edlund K, et al: Analysis of the human
tissue-specific expression by genome-wide integration of
transcriptomics and antibody-based proteomics. Mol Cell Proteomics.
13:397–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Stanchina L, Baral V, Robert F, Pingault
V, Lemort N, Pachnis V, Goossens M and Bondurand N: Interactions
between Sox10, Edn3 and Ednrb during enteric nervous system and
melanocyte development. Dev Biol. 295:232–249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wiesmann F, Veeck J, Galm O, Hartmann A,
Esteller M, Knuchel R and Dahl E: Frequent loss of endothelin-3
(EDN3) expression due to epigenetic inactivation in human breast
cancer. Breast Cancer Res. 11:R342009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nash KT and Welch DR: The KISS1 metastasis
suppressor: Mechanistic insights and clinical utility. Front
Biosci. 11:647–659. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ringel MD, Hardy E, Bernet VJ, Burch HB,
Schuppert F, Burman KD and Saji M: Metastin receptor is
overexpressed in papillary thyroid cancer and activates MAP kinase
in thyroid cancer cells. J Clin Endocrinol Metab. 87:23992002.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Savvidis C, Papaoiconomou E, Petraki C,
Msaouel P and Koutsilieris M: The role of KISS1/KISS1R system in
tumor growth and invasion of differentiated thyroid cancer.
Anticancer Res. 35:819–826. 2015.PubMed/NCBI
|
|
53
|
Dong Y, Hirane M, Araki M, Fukushima N,
Honoki K and Tsujiuchi T: Lysophosphatidic acid receptor-5
negatively regulates cell motile and invasive activities of human
sarcoma cell lines. Mol Cell Biochem. 393:17–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Takahashi K, Furukawa C, Takano A,
Ishikawa N, Kato T, Hayama S, Suzuki C, Yasui W, Inai K, Sone S, et
al: The neuromedin U-growth hormone secretagogue receptor
1b/neurotensin receptor 1 oncogenic signaling pathway as a
therapeutic target for lung cancer. Cancer Res. 66:9408–9419. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ketterer K, Kong B, Frank D, Giese NA,
Bauer A, Hoheisel J, Korc M, Kleeff J, Michalski CW and Friess H:
Neuromedin U is overexpressed in pancreatic cancer and increases
invasiveness via the hepatocyte growth factor c-Met pathway. Cancer
Lett. 277:72–81. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Harten SK, Esteban MA, Shukla D, Ashcroft
M and Maxwell PH: Inactivation of the von hippel-lindau tumour
suppressor gene induces neuromedin U expression in renal cancer
cells. Mol Cancer. 10:892011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang L, Chen C, Li F, Hua QQ, Chen S, Xiao
B, Dai M, Li M, Zheng A, Yu D, et al: Overexpression of neuromedin
U is correlated with regional metastasis of head and neck squamous
cell carcinoma. Mol Med Rep. 14:1075–1082. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lee SC, Fujiwara Y, Liu J, Yue J, Shimizu
Y, Norman DD, Wang Y, Tsukahara R, Szabo E, Patil R, et al:
Autotaxin and LPA1 and LPA5 receptors exert disparate functions in
tumor cells versus the host tissue microenvironment in melanoma
invasion and metastasis. Mol Cancer Res. 13:174–185. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yap LF, Velapasamy S, Lee HM, Thavaraj S,
Rajadurai P, Wei W, Vrzalikova K, Ibrahim MH, Khoo AS, Tsao SW, et
al: Down-regulation of LPA receptor 5 contributes to aberrant LPA
signalling in EBV-associated nasopharyngeal carcinoma. J Pathol.
235:456–465. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tsujiuchi T, Araki M, Hirane M, Dong Y and
Fukushima N: Lysophosphatidic acid receptors in cancer
pathobiology. Histol Histopathol. 29:313–321. 2014.PubMed/NCBI
|
|
61
|
Mills GB and Moolenaar WH: The emerging
role of lysophosphatidic acid in cancer. Nat Rev Cancer. 3:582–591.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357:eaan25072017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Uhlen M, Oksvold P, Fagerberg L, Lundberg
E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S,
et al: Towards a knowledge-based human protein atlas. Nat
Biotechnol. 28:1248–1250. 2010. View Article : Google Scholar : PubMed/NCBI
|
